Skip to main content
. 2005 Feb 8;92(4):681–689. doi: 10.1038/sj.bjc.6602382

Figure 3.

Figure 3

Histograms of DNA content of A549 (AC) and Calu-6 (DF) cells demonstrating the accumulation of cells in the S phase after topotecan treatment (B and E), and the minimal increase in the G1 phase after gemcitabine exposure (C and F) with respect to controls (A and D).